- Home
- AVPT vs TMDX Comparison
AVPT vs TMDX Comparison
Compare AVPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- TMDX
- Stock Information
- Founded
- AVPT 2001
- TMDX 1998
- Country
- AVPT United States
- TMDX United States
- Employees
- AVPT N/A
- TMDX N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AVPT Technology
- TMDX Health Care
- Exchange
- AVPT Nasdaq
- TMDX Nasdaq
- Market Cap
- AVPT 3.8B
- TMDX 3.9B
- IPO Year
- AVPT N/A
- TMDX 2019
- Fundamental
- Price
- AVPT $16.09
- TMDX $116.99
- Analyst Decision
- AVPT Buy
- TMDX Buy
- Analyst Count
- AVPT 4
- TMDX 10
- Target Price
- AVPT $19.75
- TMDX $122.11
- AVG Volume (30 Days)
- AVPT 1.2M
- TMDX 969.5K
- Earning Date
- AVPT 11-06-2025
- TMDX 10-27-2025
- Dividend Yield
- AVPT N/A
- TMDX N/A
- EPS Growth
- AVPT N/A
- TMDX 2163.11
- EPS
- AVPT N/A
- TMDX 2.02
- Revenue
- AVPT $373,069,000.00
- TMDX $531,292,000.00
- Revenue This Year
- AVPT $25.84
- TMDX $38.86
- Revenue Next Year
- AVPT $18.41
- TMDX $20.79
- P/E Ratio
- AVPT N/A
- TMDX $57.97
- Revenue Growth
- AVPT 24.41
- TMDX 48.09
- 52 Week Low
- AVPT $11.43
- TMDX $55.00
- 52 Week High
- AVPT $20.25
- TMDX $169.29
- Technical
- Relative Strength Index (RSI)
- AVPT 47.99
- TMDX 53.10
- Support Level
- AVPT $15.74
- TMDX $105.00
- Resistance Level
- AVPT $16.77
- TMDX $117.96
- Average True Range (ATR)
- AVPT 0.48
- TMDX 5.57
- MACD
- AVPT 0.15
- TMDX -0.28
- Stochastic Oscillator
- AVPT 62.43
- TMDX 73.18
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.